Showing results (51-60 of 133) with videos related to
Sort By:
Pageof 14
Journal of Gastroenterology and Hepatology|January 6, 2009
Confocal endomicroscopy in patients with ulcerative colitisOsamu Watanabe, Takafumi Ando, Osamu Maeda, et al.Journal of Gastroenterology and Hepatology|June 19, 2007
Prevalence and prognosis of gastric cancer detected by screening in a large Japanese population: data from a single institute over 30 yearsRyoji Miyahara, Yasumasa Niwa, Tetsuo Matsuura, et al.European Journal of Gastroenterology & Hepatology|June 9, 2007
Rugal hyperplastic gastritis increases the risk of gastric carcinoma, especially diffuse and p53-independent subtypesAkihiko Oguri, Naoki Ohmiya, Ayumu Taguchi, et al.Journal of Palliative Medicine|October 29, 2015
Prophylactic Use of Antiemetics for Prevention of Opioid-Induced Nausea and Vomiting: A Questionnaire Survey among Japanese PhysiciansHiroaki Tsukuura, Yuichi Ando, Bishal Gyawali, et al.Toxicology and Applied Pharmacology|August 25, 2006
Paeonol attenuates TNBS-induced colitis by inhibiting NF-kappaB and STAT1 transactivationKazuhiro Ishiguro, Takafumi Ando, Osamu Maeda, et al.Oncology Reports|June 21, 2006
Enhancement of GLI1-transcriptional activity by beta-catenin in human cancer cellsOsamu Maeda, Masashi Kondo, Takayoshi Fujita, et al.Cancer Medicine|March 20, 2016
Comparison of prognoses according to non-positive and positive spectrin αII expression detected immunohistochemically in epithelial ovarian carcinoma: a retrospective studyOsamu Maeda, Tomoko Miyata-Takata, Kiyosumi Shibata, et al.In Vivo (Athens, Greece)|November 4, 2020
Correlation Between the Metabolic Conversion of a Capecitabine Metabolite, 5'-Deoxy-5-fluorocytidine, and Creatinine ClearanceTakahiro Inaishi, Ken-Ichi Fujita, Natsumi Matsumoto, et al.Cancer Science|November 24, 2015
Optimal dose of gemcitabine for the treatment of biliary tract or pancreatic cancer in patients with liver dysfunctionTakashi Shibata, Tomoki Ebata, Ken-ichi Fujita, et al.Anticancer Research|February 6, 2009
Reduction of irradiation volume and toxicities with 3-D radiotherapy planning over conventional radiotherapy for prostate cancer treated with long-term hormonal therapyHideya Yamazaki, Kinji Nishiyama, Eiichi Tanaka, et al.Pageof 14